Physician profile
Queen Mcghee
NPI 1093191751
$1,037.13
in general payments reported to CMS, 2019-2025
8 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $252 · 2023: $117 · 2024: $98.43 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $235.41 | 2022-2025 | Alinity |
| Teva Pharmaceuticals USA, INC. | $216.95 | 2023-2025 | Austedo, Uzedy |
| Dexcom, INC. | $140.93 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Novo Nordisk INC | $116.90 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.43 | 2024 | Xifaxan |
| Sk Life Science, INC. | $97.52 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.40 | 2021 | |
| Medtronic, INC. | $55.59 | 2025 | Symplicity G3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Queen Mcghee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.